NOOSPHERE

Public document records

Bibliographic records with public provenance and stable links. The catalog does not include all documents in the corpus or reproduce their full texts.

98,186 public records · page 503 / 982

  1. Kratom- A Lethal Drug On The Rise2019 · OpenAlex
  2. Kratom-Induced Cholestatic Liver Injury and Its Conservative Management2019 · Crossref
  3. L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning2019 · OpenAlex
  4. La cocaïne en France, un marché en expansion : tendances actuelles et réponses publiques2019 · OpenAlex
  5. La religion du corps-marchandise : un nouvel opium du peuple ?2019 · Crossref
  6. Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age2019 · OpenAlex
  7. Lactate: A Novel Signaling Molecule in Synaptic Plasticity and Drug Addiction2019 · Crossref
  8. Lasting effects of repeated ∆ 9 ‐tetrahydrocannabinol vapour inhalation during adolescence in male and female rats2019 · OpenAlex
  9. Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepam2019 · Crossref
  10. LC-MS/MS Analysis of Sugars, Alditols, and Humectants in Smokeless Tobacco Products2019 · Crossref
  11. Le façonnement neuropharmacologique de la culture. Anthropologie comparée des rituels à hallucinogènes sérotoninergiques et anticholinergiques2019 · OpenAlex
  12. Lead Poisoning in Opium-Addicted Subjects, Its Correlation with Pyrimidine 5′-Nucleotidase Activity and Liver Function Tests2019 · Crossref
  13. Leaders see harm reduction being further ingrained in 20192019 · Crossref
  14. Learning Attraction Field Representation for Robust Line Segment Detection2019 · OpenAlex
  15. Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States.2019 · PubMed
  16. Legal Treatment of Foreign Drug Offenders Who Face Capital Punishment in China2019 · Crossref
  17. Legalization of marijuana takes another step forward2019 · Crossref
  18. Legalized Cannabis in Colorado Emergency Departments: A Cautionary Review of Negative Health and Safety Effects2019 · OpenAlex
  19. Legitimacy in Criminal Governance: Managing a Drug Empire from Behind Bars2019 · OpenAlex
  20. Legitimacy in Criminal Governance: Managing a Drug Empire from Behind Bars2019 · OpenAlex
  21. Leisure-Time Sedentary Behavior Is Associated with Psychological Distress and Substance Use among School-Going Adolescents in Five Southeast Asian Countries: A Cross-Sectional Study2019 · Crossref
  22. Lessons from Scott County — Progress or Paralysis on Harm Reduction?2019 · OpenAlex
  23. Lessons learned from ramping up a Canadian Take Home Naloxone programme during a public health emergency: a mixed-methods study2019 · OpenAlex
  24. Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy2019 · OpenAlex
  25. Lessons on the Drug War from an Enemy2019 · Crossref
  26. Lessons to be learned from toxicological analyses in intoxicated patients and seized materials at an electronic music dance festival2019 · OpenAlex
  27. Lethal and Sublethal Toxicity of Thiamethoxam and Clothianidin Commercial Formulations to Soil Invertebrates in a Natural Soil2019 · Crossref
  28. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders2019 · OpenAlex
  29. Life after opioid‐involved overdose: survivor narratives and their implications for ER/ED interventions2019 · OpenAlex
  30. Life Experiences with Substance Use of Substance Addicts Being Treated a Second Time in AMATEM2019 · Crossref
  31. Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model2019 · OpenAlex
  32. Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth2019 · OpenAlex
  33. LIFESPAN CANNABIS USE PATTERNS IN OLDER USERS2019 · Crossref
  34. Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome2019 · OpenAlex
  35. Lifetime Drinking History of Persons With Chronic Pancreatitis2019 · Crossref
  36. Life‐course trajectories of cannabis use: a latent class analysis of a New Zealand birth cohort2019 · Crossref
  37. Life‐long impairment of glucose homeostasis upon prenatal exposure to psychostimulants2019 · OpenAlex
  38. Ligand based screening of chemical constituents from African medicinal plants for the identification of MAOB inhibitors2019 · Crossref
  39. LIMITATIONS ON THE SCIENTIFIC STUDY OF DRUG‐ENABLED MYSTICAL EXPERIENCES2019 · Crossref
  40. Linking parental incarceration and family dynamics associated with intergenerational transmission: A life‐course perspective*2019 · OpenAlex
  41. Links between transactional sex and HIV/STI-risk and substance use among a large sample of European men who have sex with men2019 · OpenAlex
  42. Liquid chromatography–tandem mass spectrometry screening method using information‐dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine2019 · Crossref
  43. Lithium does not extend antidepressant effects of ketamine infusions2019 · Crossref
  44. Lithium treatment, nephrogenic diabetes insipidus and the risk of hypernatraemia: a retrospective cohort study2019 · Crossref
  45. Lived Experience: Characteristics of Workers in Alcohol and Other Drug Nongovernment Organizations2019 · Crossref
  46. Livelihood Pattern of Betel Leaf Cultivators: A Case Study at Fakirhat Upazila in Bagerhat District of Bangladesh2019 · Crossref
  47. Living in Fear: The Dynamics of Extortion in Mexico’s Drug War2019 · OpenAlex
  48. Local Alcohol Policy Implementation in Scotland: Understanding the Role of Accountability within Licensing2019 · Crossref
  49. Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons2019 · OpenAlex
  50. Long-lasting analgesic effect of the psychedelic drug changa: A case report2019 · OpenAlex
  51. Long-Term Behavioral Effects of Post-weaning Social Isolation in Males and Females2019 · OpenAlex
  52. Long-Term Drug Misuse Increases the Risk of Cognitive Dysfunctions in Intimate Partner Violence Perpetrators: Key Intervention Targets for Reducing Dropout and Reoffending2019 · OpenAlex
  53. Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines from the Section of Pharmacotherapy of Polish Society for Research on Addictions (PTBU) and the Section of Psychopharmacology of Polish Psychiatric Association (PTP) – 2019 update2019 · Crossref
  54. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study2019 · OpenAlex
  55. Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine2019 · OpenAlex
  56. Longitudinal changes in cocaine intake and cognition are linked to cortical thickness adaptations in cocaine users2019 · OpenAlex
  57. Longitudinal relations between substance use abstinence motivations and substance use behaviors in adolescence: A self‐determination theory approach2019 · Crossref
  58. Long‐acting antipsychotic medication as first‐line treatment of first‐episode psychosis with comorbid substance use disorder2019 · Crossref
  59. Long‐lasting microbial dysbiosis and altered enteric neurotransmitters in adult rats following adolescent binge ethanol exposure2019 · Crossref
  60. Long‐term effectiveness of oral second‐generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta‐analysis of direct head‐to‐head comparisons2019 · OpenAlex
  61. Long‐term effects of youth unemployment on alcohol‐related morbidity2019 · Crossref
  62. Long‐term opioid therapy definitions and predictors: A systematic review2019 · OpenAlex
  63. Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder2019 · OpenAlex
  64. Long‐term use of methylphenidate continues to confer benefits2019 · Crossref
  65. Loperamide-Associated Opioid Use Disorder and Proposal of an Alternative Treatment with Buprenorphine2019 · Crossref
  66. Los circuitos de la droga. Sus repercusiones en el mundo contemporáneo2019 · OpenAlex
  67. Los Movimientos Sociales de Bolivia Como Actores Contrahegemónicos en el Régimen Internacional de Control de Drogas2019 · OpenAlex
  68. Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco2019 · OpenAlex
  69. Low stress resilience in late adolescence and risk of smoking, high alcohol consumption and drug use later in life2019 · Crossref
  70. Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium2019 · OpenAlex
  71. Lower circulating endocannabinoid levels in children with autism spectrum disorder2019 · OpenAlex
  72. LSD 3.0: a comprehensive resource for the leaf senescence research community2019 · Crossref
  73. LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making2019 · OpenAlex
  74. LSD impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision making2019 · OpenAlex
  75. Lung injury from inhaling butane hash oil mimics pneumonia2019 · OpenAlex
  76. Lysergic acid diethylamide (LSD)2019 · OpenAlex
  77. l‐α‐Lysophosphatidylinositol ( LPI ) aggravates myocardial ischemia/reperfusion injury via a GPR 55/ ROCK ‐dependent pathway2019 · OpenAlex
  78. Machine Learning and Natural Language Processing for Geolocation-Centric Monitoring and Characterization of Opioid-Related Social Media Chatter2019 · OpenAlex
  79. Machine learning: assessing neurovascular signals in the prefrontal cortex with non-invasive bimodal electro-optical neuroimaging in opiate addiction2019 · OpenAlex
  80. Macrocytosis among patients with heroin use disorder2019 · OpenAlex
  81. Magnesium Preparations in Psychiatry, Addiction Medicine, Neurology and General Medicine (Part I. History)2019 · OpenAlex
  82. Main approaches and development’s tendencies of rehabilitation of addicted to psychoactive substances persons2019 · Crossref
  83. Making drug policy in summer—drug checking in Australia as providing more heat than light2019 · Crossref
  84. Making measurement‐based care for addictions a reality in primary care2019 · Crossref
  85. Making Problems: The Inventive Potential of the Arts for Alcohol and Other Drug Research2019 · Crossref
  86. Making the business case for an addiction medicine consult service: a qualitative analysis2019 · Crossref
  87. Man and the Microbiome: A New Theory of Everything?2019 · OpenAlex
  88. Management and monitoring of opioid use in pregnancy2019 · OpenAlex
  89. Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic2019 · OpenAlex
  90. Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine2019 · OpenAlex
  91. Management of Opioid Use Disorder Treatment2019 · Crossref
  92. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques2019 · Crossref
  93. Management of withdrawal from alcohol and other drugs2019 · OpenAlex
  94. Managing Cancer Pain, Monitoring for Cancer Recurrence, and Mitigating Risk of Opioid Use Disorders: A Team-Based, Interdisciplinary Approach to Cancer Survivorship2019 · OpenAlex
  95. Managing Opioid Use in Orthopaedic Patients Through Harm Reduction Strategies2019 · OpenAlex
  96. Managing the Second “A” in Alcoholics Anonymous2019 · Crossref
  97. Maori and kava: New drug fashion or re-engagement with 'kawa'?2019 · OpenAlex
  98. Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden2019 · OpenAlex
  99. Mapping Psilocybin-Assisted Therapies: A Scoping Review2019 · OpenAlex
  100. Mapping the physiological and molecular markers of stress and SSRI antidepressant treatment in S100a10 corticostriatal neurons2019 · OpenAlex